Main Article Content
Background: Lornoxicam is a potent non-steroidal anti-inflammatory drug (NSAID) that possesses gastrointestinal tract (GIT) associated problems like gastric irritation. Transdermal patches can overcome the gastrointestinal tract associated problems of the drug and can be an alternate and convenient dosage form as compared to oral dosage forms. Three natural penetration enhancers i.e. Eugenol, Cineole and Limonene, were known to enhance the permeation of drugs from the patch.
Objective: The present study aimed to prepare and evaluate transdermal drug delivery patches for sustained release of Lornoxicam using HPMC E50 as polymer and to study the effects of three potential permeation enhancers viz. Limonene, Eugenol, and Cineole at different concentrations on permeation of Lornoxicam from patches.
Materials and Methods: Limonene, Eugenol, and Cineole at concentrations of 1, 2, 3, and 4% were used as permeation enhancers in the formulation of Lornoxicam transdermal patches. Hydroxy Propyl Methyl Cellulose (1:5 drug: polymer ratio) and plasticizers like glycerine was used to prepare transdermal patches, including three permeation enhancers. A total of 12 formulations (F1-F12) were prepared with each enhancer at four different concentrations and evaluated for various parameters like thickness, weight variation, Water-Vapor Permeability, Tensile Strength, Percent Moisture Uptake, Drug Content, and Diffusion studies.
Results: The partition coefficient was determined in octanol/water system, and it indicates that the drug is suitable for transdermal drug delivery. IR spectroscopy was performed to determine the physicochemical compatibility between drugs and the polymers, and the results suggested no physicochemical incompatibility between drugs and the polymers. The Optimized formulation F4 containing 4% Limonene as a permeation enhancer gave a maximum release 82.85% over a period of 24 hours. Kinetics data of formulations showed that all the twelve formulations followed first-order kinetics and except two formulations (i.e., F3 and F12) follow anomalous transport. Stability studies were carried out as per ICH guidelines, and formulations were found to be Stable. A transdermal patch containing Limonene as a permeation enhancer showed higher in vitro release of Lornoxicam as compared to other penetration enhancers.
Conclusion: All 12 formulations, i.e., F1-F12, showed good physicochemical characteristics and showed an increase in permeation of drugs during their in vitro permeation study. This dosage form also showed improved patient compliance due to a simplified therapeutic regimen and comfort via the non-invasive, painless, and simple application. The optimized formulation can be exploited further to overcome the GIT associated drawbacks of Lornoxicam.
How to cite this article: Sharma, N., Sharma, S. and Kaushik, R. (2019). Formulation and Evaluation of Lornoxicam Transdermal patches using various Permeation Enhancers. International Journal of Drug Delivery Technology, 9(4): 597-607.
Source of support: Nil.
Conflict of interest: None.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.